, but their roles in regulating sleep remain unclear. The zona incerta, which is adjacent to the lateral hypothalamus, regulates sensory-motor integration and sends efferent projections to multiple brain regions 5
. Multiple inhibitory neuronal subtypes innervate Hcrt + lateral hypothalamus neurons 4 , but their roles in regulating sleep remain unclear. The zona incerta, which is adjacent to the lateral hypothalamus, regulates sensory-motor integration and sends efferent projections to multiple brain regions 5 . Stimulation of thalamic afferents to the zona incerta can induce a sleep-like state 6 . Although bilateral ablation of the zona incerta does not affect sleep 7 , the role of individual zona incerta cell types in controlling sleep is unknown.
We previously observed Lhx6 expression in a subset of GABAergic neuronal precursors in the developing mouse hypothalamus from embryonic day (E)11.5 onwards 8 . We identified an eGFP transgenic line 9 that recapitulated native expression of Lhx6 in the brain (98% of eGFP + cells are Lhx6 + ; Extended Data Fig. 1a -e). In diencephalon, Lhx6 was expressed in a zone extending from the ventral zona incerta (VZI), through the dorsomedial hypothalamic nucleus and lateral hypothalamus, to the posterior hypothalamus 8 (Fig. 1a, b and Extended Data Fig. 1a-d ). To study these cells, we used Lhx6-cre transgenic mice 10 , which showed co-expression of Lhx6 protein and tdTomato when crossed with the Ai9 reporter (Extended Data Fig. 2a-e) .
Hypothalamic Lhx6 + cells express markers of GABAergic neurons, including Gad1 and Slc32a1 (Fig. 1e-g and Extended Data Fig. 1f-i) . Although Lhx6 is expressed in parvalbumin-positive (Pvalb + ) and somatostatin-positive (Sst + ) cortical interneurons, and is necessary for their differentiation 11 , we observed no colocalization of Lhx6 with either Pvalb or Sst in the zona incerta or lateral hypotha lamus (Extended Data Fig. 1j-q) . Additionally, Lhx6
+ cells in the lateral hypothalamus expressed neither Hcrt nor the sleep-promoting neuropeptide melanin-concentrating hormone (MCH) 1 (Extended Data Fig. 2f-k) .
Lhx6 + cells represent 45% and 33% of all Slc32a1 + and Gad1 + cells in the VZI (Fig. 1c, d ). Following AAV9-DIO-ChR2-eYFP virus injections into the zona incerta of Lhx6-creER T2 knock-in mice 12 ( Fig. 1h ), we observed local projections within the zona incerta and to Hcrt + neurons in the lateral hypothalamus (Fig. 1i, j) . Projections to monoaminergic midbrain populations were seen, including to the substantia nigra, the ventral tegmental area and the dorsal raphe nucleus, as well as to the ventrolateral periaqueductal grey and the central amygdala (Extended Data Fig. 3b , e, h, k, n). These overlap with known projections of GABAergic neurons of the zona incerta 13 (Extended Data Fig. 3c , f, i, l, o), but differ in that no projections from Lhx6 neurons of the zona incerta to the thalamus-the main target of Pvalb + GABAergic neurons of the zona incerta-were seen (Extended Data Fig. 3d , g, j, m, p).
To map inputs to Lhx6 + VZI neurons, we conducted retrograde monosynaptic tracing using rabies virus 14 , and observed labelling in many brain regions, including reciprocal connections between all regions innervated by Lhx6
+ VZI neurons, along with other regions that control sleep. Lhx6
+ VZI neurons appear to receive inputs from wake-active and REM-inhibiting neurons, including dopaminergic neurons of the ventral tegmental area, serotoninergic neurons of the dorsal raphe nucleus, and GABAergic neurons of both the ventrolateral periaqueductal grey and lateral hypothalamus 1,3,15 ( Fig. 1k , o-t and Extended Data Fig. 4 ). Lhx6
+ VZI neurons also receive projections from REM-promoting cholinergic neurons of the basal forebrain and pedunculopontine nucleus 1, 3 (Fig. 1l -n and Extended Data Fig. 4 ). Finally, we observed inputs from other regions that have not previously been implicated in sleep regulation (Extended Data Fig. 4) .
We next tested whether Lhx6 + VZI neurons were activated during sleep. We observed higher Fos expression at lights on, when sleep pressure is highest, relative to lights off, when sleep pressure is lowest 16 ( Fig. 2a-e) . We then showed that 6-h sleep deprivation from zeitgeber time (ZT)0 (lights on) to ZT6-either alone or in combination with 1 h of recovery sleep from ZT6 to ZT7-increased Fos expression in Lhx6 + VZI neurons (Fig. 2f-h ), demonstrating that Lhx6 + VZI neurons are activated by high sleep pressure.
To test whether Lhx6 + VZI neurons directly inhibit wake-promoting Hcrt + neurons in the lateral hypothalamus, we performed whole-cell patch-clamp recordings in brain slices from Lhx6-cre;Hcrt-eGFP mice 17 infected with AAV9-DIO-ChR2-mCherry (Extended Data Fig. 5a ). mCherry + neurons fired action potentials in current-clamp mode following photostimulation (Fig. 2i) . Photostimulation of Lhx6 + VZI neurons induced short-latency postsynaptic responses (1.82 ± 0.22 ms; n = 21) in Hcrt-eGFP + neurons recorded using high-chloride internal solution ( , d) . e-g, Co-localization of Lhx6-eGFP (e, green) with Gad1 mRNA (f, red) in the VZI. Merged image is shown in g. h, ChR2-eYFP virus injection site in the zona incerta of the Lhx6-cre line. i, j, Distribution of ChR2-eYFPinfected Lhx6
+ neurons (green) in the zona incerta (i) and projections of Lhx6 + neurons in the lateral hypothalamus (j). Tyrosine hydroxylase (TH) (i, red), and Hcrt (j, red) are shown. k, Rabies virus (RABV) injection site in the zona incerta of Lhx6-cre, and the distribution of neurons presynaptic to Lhx6 + VZI cells. l-n, RABV + cells in the nucleus of the diagonal band (l, red) stained with anti-Chat (m, grey). Merged image is shown in n. o-q, RABV + cells in the ventral tegmental area (o, red) stained with anti-tyrosine hydroxylase (p, grey). Merged image is shown in q. r-t, RABV + cells in the dorsal raphe nucleus (r, red) stained with anti-TPH2 (s, grey). Merged image is shown in t. Scale bars, 100 μ m. Arrows show cells co-expressing relevant markers. Amy, amygdala; CeA, central nucleus of the amygdala; Cg1/Cg2, cingulate cortex; DB, diagonal band; DpG, motor-related nuclei of superior colliculus; Gi, midline gigantocellular nucleus of the medulla; LH, lateral hypothalamus; LO/VO, lateral/ventral orbital cortex; LS, lateral septum; M1/M2, frontal/ secondary motor cortex; POA, preoptic area; PPTG, pedunculopontine tegmental nucleus; RtTg, midbrain reticular formation; SFO, subfornical organ; SNR/VTA, substantia nigra reticular part/ventral tegmental area; vlPAG/DR, ventrolateral periaqueductal grey/dorsal raphe nucleus; VTA/SNPC, ventral tegmental area/substantia nigra pars compact; ZI, zona incerta.
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were unaffected by ionotropic glutamate receptor antagonists, and eliminated by the GABA A receptor antagonist gabazine (Fig. 2k, l) . Responses recorded with co-application of the potassium channel blocker 4-AP and tetrodotoxin 18 indicate that Lhx6 + VZI neurons form monosynaptic connections onto Hcrt-eGFP + neurons (Extended Data  Fig. 5c, d) .
We also tested whether Lhx6 + VZI neurons inhibited wakepromoting GABAergic neurons in the lateral hypothalamus 15 , using + neurons in the zona incerta across ZT (c) and under sleep pressure (h). * * P < 0.01; linear mixed-effect model fit by REML (h), two-tailed one-way ANOVA (c). n = 4 mice per group, four brain sections analysed bilaterally per mouse. i, Average response to photostimulation (500 ms) of a ChR2-expressing Lhx6 + VZI neuron (left; voltage-clamp) and action potentials elicited by photostimulation (3 ms, 10 Hz) from the same neuron (right; current-clamp). j, Responses of two Hcrt + neurons to depolarizing current steps. k, Postsynaptic responses from a Hcrt + neuron following photostimulation of ChR2 + Lhx6 + neurons under control conditions (left), with glutamate receptor blockers NBQX (2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide disodium salt) and CPP ((RS)-3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid) (CPP + NBQX; middle), CPP, NBQX and the GABA A receptor antagonist gabazine (6-imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid hydrobromide) (CPP + NBQX + gabazine; right) and after gabazine washout (far-right). Inset shows the onset of the postsynaptic response shown at an expanded timescale for the control. l, Amplitudes of the first postsynaptic response to photostimulation in control conditions, with NBQX and CPP, with NBQX, CPP and gabazine, and after gabazine washout. Two-way ANOVA with Bonferroni correction; control versus CPP + NBQX, P = 1; CPP + NBQX versus CPP + NBQX + gabazine, * * * P = 0.00024; control versus CPP + NBQX + gabazine, * * * P = 0.00077; CPP + NBQX versus CPP + NBQX + gabazine washout, * P = 0.0478; n = 8 Hcrt neurons from four mice. m-p, Responses to depolarizing current steps (left) and average short-latency postsynaptic potentials (right) in Gad2 + neurons following photostimulation of ChR2 + Lhx6 + neurons. Data are mean ± s.e.m. (c, h, l).
Lhx6-cre;Gad2-NLS-mCherry mice and the approach described above. The Gad2-mCherry + cells showed a range of firing patterns following current steps, as described 19 ( Fig. 2m-p) . Gad2-mCherry + neurons in the lateral hypothalamus exhibited short-latency postsynaptic responses following photostimulation of Lhx6 + VZI neurons, which were eliminated by gabazine, similar to Hcrt + neurons (1.83 ± 0.19 ms, n = 10; Fig. 2m -p and Extended Data Fig. 5h-l) .
Reciprocal connections among GABAergic neurons can facilitate transitions between bistable activity states, including sleep-wake transitions 3, 20, 21 . We tested whether Lhx6 + VZI GABAergic neurons were interconnected, using Lhx6-creER T2 ;Lhx6-eGFP mice and the approaches described above (Extended Data Fig. 5m-u) . We observed short-latency postsynaptic potentials in a subset of Lhx6 + cells, indicating interconnectivity (Extended Data Fig. 5q, r) .
We next selectively deleted Lhx6 in diencephalon 22 ( Fig. 3a) . Foxd1-cre; Lhx6 lox/lox mice show loss of Lhx6 immunostaining in the hypothalamus, but not in the telencephalon (Extended Data Fig. 6a-l) . Foxd1-cre;Lhx6 lox/lox mice show no gross behavioural abnormalities (Extended Data Fig. 6q-v) . However, electroencephalogram (EEG) and electromyography (EMG) data from Foxd1-cre;Lhx6 lox/lox mice revealed an increase in wake time, and a reduction in NREM and REM sleep, relative to controls (Fig. 3b) . Spectral analysis of EEGs from Foxd1-cre;Lhx6 lox/lox mice showed a reduction in delta waves during NREM sleep (Fig. 3c, d ) and an increase in alpha waves during wake (Fig. 3e, f) . The relative decrease of REM sleep was greater than that of NREM sleep. Further analysis revealed an increase in wake bout length in Foxd1-cre;Lhx6 lox/lox mice (Extended Data Fig. 6o, p) . This shows that selective deletion of Lhx6 from the diencephalon resulted in decreased sleep.
Using DREADD (designer receptors exclusively activated by designer drugs)-based chemogenetic analysis 23 , we next tested whether activation and inhibition of Lhx6 + VZI neurons modulated sleep. In Lhx6-cre mice infected bilaterally with G q -coupled DREADDs, clozapine N-oxide (CNO) induced Fos expression in zona incerta cells (Fig. 4a, b and Extended Data Fig. 7h-k) , and did not affect sleep in mice expressing mCherry in Lhx6 + VZI neurons (Extended Data Fig. 7p-r) . We next tested whether activation of Lhx6 + VZI neurons induced sleep. We observed an increase in REM sleep during the 12 h following CNO injection at all times except ZT23, when sleep pressure is highest. Decreases in wake, and increases in NREM sleep, were observed following CNO administration at ZT5 and ZT11 (Fig. 4c, d and Extended Data Fig. 8 ). These effects were strongest between 2 and 8 h following CNO administration, and were gone after 12 h. CNO injection at ZT5 increased delta waves during NREM sleep and decreased theta and gamma waves during wake (Extended Data Fig. 8 ). Selective transduction of Lhx6
+ VZI neurons was confirmed by postmortem examination (Extended Data Fig. 7a-g ).
To determine whether activation of Lhx6 + VZI neurons promotes sleep by inhibiting Hcrt + neurons, we performed a pharmacological occlusion experiment, where we activated Lhx6 + zona incerta neurons while applying the dual hypocretin receptor antagonist suvorexant 24 . As reported, suvorexant rapidly increased both NREM and REM sleep, but these effects were lost by 4 h (Extended Data Fig. 9 ). Combining CNO and suvorexant resulted in levels of wake and of NREM sleep, but not of REM sleep, indistinguishable from those seen with suvorexant alone, indicating that Lhx6 + zona incerta neurons control Hcrt release to promote NREM, but not REM, sleep.
Finally, we show that inhibition of Lhx6 + VZI neurons with G i -coupled DREADDs reduced sleep (Fig. 4a , e-g and Extended Data Fig. 10 ). CNO administration at ZT5 and ZT11 reduced time spent in REM sleep. A decrease in time spent in NREM sleep, and corresponding increase in time awake, were also observed following CNO administration at ZT5 (Fig. 4f) , along with a decrease in delta waves during NREM sleep (Extended Data Fig. 10 ). CNO administered at ZT5 inhibited NREM and REM sleep, and increased wake, for up to 8 h following injection (Fig. 4g ). No significant change was seen in total time spent in wake, NREM or REM sleep in the 12 h following CNO injection in the middle or the end of the dark phase at ZT17 and ZT23 (Extended Data Fig. 10 ). When data were examined in two-hour bins, decreases in NREM and REM sleep, and a corresponding increase in wake, were observed 8-10 h following CNO administration. These decreases occurred during the beginning of the light phase (Extended Data Fig. 10 ), suggesting that the sleep-inhibiting effects of Lhx6 + VZI neurons are confined to the normal sleep time of mice (light phase) (Fig. 2h) .
In this study, we identify GABAergic Lhx6 + VZI neurons as a subpopulation of sleep-promoting neurons. These join a handful of other GABAergic sleep-promoting neuronal populations, including cells in the ventrolateral preoptic area and the parafacial zone of the medulla [25] [26] [27] . Lhx6
+ VZI neurons differ from these sleep-promoting cells in that they promote both NREM and REM sleep, rather than either alone. They also exhibit a relatively slow-onset but long-lasting regulation of sleep, which may be related to their interconnectivity, a property that they share with other GABAergic zona incerta neurons 28 .
Lhx6
+ VZI neurons receive inputs from multiple different subtypes of sleep-regulating neurons, and are directly presynaptic to wakepromoting GABAergic and Hcrt + neurons of the lateral hypothalamus and inhibit their activity, with this latter function being essential e, FFT analysis of EEG power spectrum frequency in cKO mice (blue) compared to controls (red). f, The collapsed EEG frequency data are shown for control (red) and cKO (blue) mice. n = 8 control and 8 cKO mice for all experiments. Data are mean ± s.e.m. * P < 0.05, * * P < 0.01; two-way ANOVA followed by Sidak's post hoc test.
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for their promotion of NREM sleep. Since complete ablation of the zona incerta does not induce changes in sleep-wake cycles 7 , and global activation of GABAergic neurons in the zona incerta does not affect sleep 15 , these findings imply that other wake-promoting GABAergic subpopulations exist in the zona incerta.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. injection of saline or CNO at ZT5 in hM3Dq mice. e, hM4Di-mCherry viral construct and injection site in Lhx6-cre mice. f, Percentage of time spent during the 12 h after injection in wake (top), NREM sleep (middle) and REM sleep (bottom) in saline-or CNO-injection in hM4Di mice. g, Percentage of time in wake (top), NREM sleep (middle) and REM sleep (bottom) in 2-h bins following injection of saline or CNO at ZT5 in hM4Di mice. * P < 0.05, * * P < 0.01, * * * P < 0.001; two-way ANOVA followed by Sidak's post hoc test. n = 8 mice for all experiments. Data are mean ± s.e.m. 17 . Lhx6-cre mice were shared by A. Gittis (Carnegie Mellon University) and were originally generated by N. Kessaris (University College London) 10 . Lhx6-creER T2 knock-in mice were generated by Z. J. Huang (Cold Spring Harbour Laboratories) 12 and were purchased from The Jackson Laboratory (stock number: 010776). Foxd1-cre-eGFP knock-in mice 29 (stock number: 012463) and Gad2-T2a-NLS-mCherry mice 30 (stock number: 023140) were obtained from The Jackson Laboratory. The conditional Lhx6 allele was generated through homologous recombination using a targeting construct in which loxP sites were placed in non-coding regions that are 5′ to coding exon 1b and 3′ to coding exon 3. The 5′ homology consists of a 3.1-kb XbaI-SacI fragment containing the 5′ upstream region and the first exon (1a) of Lhx6, whereas the 3′ homology consists of a 5.4-kb ApaI-NheI fragment. For the Lhx6-targeting vector, the 2-kb genomic fragment between the homology regions is replaced by a 4-kb cassette, containing the following: (1) the 1b, 2 and 3 coding exons flanked by loxP sites; (2) the neomycin-resistance gene under the control of the phosphoglycerate kinase (PGK) promoter (PGK-Neo) flanked by FRT sites. Targeting constructs were linearized and electroporated into E14Tg2A embryonic stem cells. Targeted clones were identified and analysed in detail by Southern blotting using 5′ and 3′ external probes. Germline transmission of the mutant alleles was achieved using standard protocols. The phenotypic analysis presented was performed on mice from which the PGK-Neo cassette was removed by crossing founder Lhx6 lox/lox mice with the Actb::FlPe transgenic line 31 . For the maintenance of the Lhx6 lox/lox colony, we performed PCR using the following primers: Lhx6flR: GGAGGCCCAAAGTTAGAACC Lhx6flF: CTCGAGTGCTCCGTGTGTC. Behavioural analysis of Foxd1-cre;Lhx6 lox/lox mice. We conducted several behavioural tests to investigate the phenotype of Foxd1-cre;Lhx6 lox/lox mice (Extended Data Fig. 6 ). Light-dark preference test. Each mouse was placed in an apparatus consisting of a dark chamber and a light-illuminated chamber. Mice could move freely between the two chambers. The duration each mouse spent in the dark chamber, light chamber or centre was measured and normalized relative to the entire experimental period.
Elevated plus maze (EPM).
Each mouse was placed in the centre of the EPM and videotaped for 5 min. The time spent in the open and closed arms was determined from the video recording by blinded observers. Open field test. Mice were placed in the open field chamber and time spent in the centre and periphery was assessed for 30 min, using a Photobeam activity system to measure beam breaks. Rotarod. Up to four mice were tested at one time on a rotating rod with the capacity to gradually accelerate up to 99.9 revolutions per minute (r.p.m.). A photobeam activity system was used to record when the mouse dropped off of the rod as the rotation speed gradually increased. The average terminal rotation speed and time spent on the Rotarod was used for analysis. Grip strength. Forelimb grip strength was measured as tension force using a computerized grip strength meter (GSM). Mice were lifted over the baseplate by their tails, and their forepaws allowed to grasp the steel grip. The tail of each mouse was then placed in the centre of the Single Axis Grip Strength Alignment Tool (SAGSAT) and the mouse was then gently pulled backward by the tail until its grip was released. The GSM was then used to measure the maximal force before the mouse released the bar. Three trials were performed for each mouse with a 1-min resting period between trials. Fos analysis. To characterize zona incerta Lhx6 neurons activated under different lighting conditions, adult Lhx6-eGFP mice (2-4 months old) were deeply anaesthetized with ketamine at four time points across the light-dark cycle: 07:00 (ZT0); 13:00 (ZT6); 21:00 (ZT14, lights off); 01:00 (ZT18). For the 07:00 time point, mice were anaesthetized a few minutes before lights on with minimal light exposure. All other mice were anaesthetized within 15 min of their time-point group. Immediately after anaesthesia, mice were transcardially perfused with 20 ml 1× phosphate-buffered saline (PBS) followed by 4% paraformaldehyde (PFA) (m/v) in 1× PBS. For analysis of Fos expression during sleep deprivation, adult Lhx6-eGFP mice (2-4 months old) were sleep-deprived starting at 07:00 (ZT0) until 13:00 for a total of 6 h. To facilitate sleep deprivation, EEG-implanted mice were monitored in new cages with new bedding, given water and food ad libitum, and occasionally touched gently with a soft brush when they seemed drowsy, as previously described 32 . Control mice were not disturbed and allowed to sleep freely. Mice in the sleep deprivation group and control group were anaesthetized at 13:00 and transcardially perfused and stained according to the protocol for immunohistochemistry. Mice in the sleep deprivation with recovery sleep group were permitted to sleep at 13:00 for 1 h and then perfused at 14:00. Cell counting. For quantification of co-localization of Lhx6 and other histological markers, the area used for counting was demarcated by the Lhx6 cells in the zona incerta that were labelled by Lhx6-eGFP. All cell counting was conducted blind on 3 × 2 tiled images of the zona incerta using ImageJ. For each mouse, brain sections were analysed bilaterally, and the percentage of marker-positive neurons in Lhx6-eGFP + neurons was compared by nonparametric statistical methods (see 'Statistics'). Stereotaxic AAV injection and EEG/EMG implantation. Surgery. AAV vectors were obtained from vector cores of the University of Pennsylvania (AAV9-EF1a. DIO.hChR2-eYFP) 33 ( Fig. 1 and Extended Data Fig. 4) and University of North Carolina (AAV9-EF1a.DIO.hM3Dq-mCherry; AAV9-EF1a.DIO.hM3Dq-eYFP; AAV9-EF1a.DIO.hM4Di-mCherry) 23 . For bilateral stereotaxic injection of AAV into the zona incerta, adult male mice (2-4 months old) were anaesthetized with ketamine/xylazine (100 μ l of 100 mg ml −1 ketamine, 20 mg ml −1 xylazine) and placed in a stereotaxic frame. The scalp was incised to expose the skull and connective tissue was gently scraped away. After exposing the skull, bilateral craniotomies (~ 1 mm diameter each) were made to allow virus delivery (600-800 nl at 40 nl min ). Stereotaxic coordinates: AP: − 1.54 mm, L: 0.55 mm, DV: − 4.8 mm, according to the reference atlas in ref. 34 . Skin covering the boreholes was sutured closed following surgery. Lhx6-creER T2 mice that were injected with ChR2-eYFP constructs to map postsynaptic projections of Lhx6 VZI neurons, beginning one week following viral injection, 1.0 mg of 4-hydroxytamoxifen dissolved in corn oil was administered via intraperitoneal injection once a day for a total of five days in order to activate expression of the Cre-dependent channelrhodopsin (ChR2) construct.
For EEG/EMG recordings, four-channel tethered EEG/EMG biosensors (Pinnacle Technology Inc.) were anchored onto the mouse skull. The two front screws used for EEG1 signal recording were positioned at: AP: + 2 mm, ML: ± 1.5 mm. The two back screws used for the EEG2 signal recording were positioned at: bregma AP: − 4 mm, ML: ± 1.5 mm. With the same implant, two EMG antenna electrodes were inserted into the left and right neck muscles. The EEG/EMG recording implant was secured to the mouse skull with dental cement. For EEG/EMG analysis of DREADD-injected mice, this surgery was performed immediately following AAV injection. EEG/EMG recording. For all analysis of sleep behaviour, the Pinnacle Technology EEG/EMG tethered recording system for sleep behaviour evaluation was used, and mice were allowed a minimum of 10 days recovery in a 12-h light-dark cycle following EEG/EMG biosensor implantation. Implanted mice were tethered to a 100× preamplifier (Pinnacle Technology) and were housed in a 12-h dark-12-h light cycle (lights on between 07:00 (ZT0) and 19:00 (ZT12)) recording chamber. The mice were allowed around 5-7 days to acclimatize to the recording chamber before recording. The EEG and EMG signals were preamplified 5,000× and digitized at 14 bits and then recorded. Signal acquisition was obtained using the Sirena acquisition suite (Pinnacle Technology Inc.). EEG/EMG traces were recorded for 48 h for Foxd1-cre;Lhx6 lox/lox mice, and data from the second day extracted for analysis ( Fig. 3 and Extended Data Fig. 6 ). For analysis of mice injected with AAVexpressing cre-dependent G q -and G i -linked DREADD constructs, we used the virus-transfected mice with saline injection as control compared to mice with clozapine-N-oxide (CNO, Sigma-Aldrich; 0.5 mg kg −1 in saline) intraperitoneal injection. The following injection protocol was used for analysis of all mice injected with AAV-expressing Cre-dependent DREADD constructs: on day 1, we performed two consecutive saline injections at 12-h intervals at ZT23 (06:00) and ZT11 (18:00); on day 2, we injected CNO at ZT23 and ZT11. Alternatively, on day 1, the saline was injected at ZT5 and ZT17, and CNO at the same times on day 2 (Fig. 4 and Extended Data Figs 8-10 ). For analysis of mice injected with AAV-expressing Cre-dependent G q DREADDs with suvorexant, a dual orexin receptor antagonist 35 , we used the virus-transfected mice with saline injection as controls. These were directly compared to mice that were administered CNO by intraperitoneal injection; suvorexant (Selleckchem; 25 mg kg −1 in 20% TPGS) was administered by oral gavage as described previously 24 ; or mice were simultaneously treated with CNO and suvorexant. The following injection protocol was used for analysis of all mice injected with AAV-expressing Cre-dependent DREADDs: on day 1, we performed one saline injection at ZT5 (12:00); on day 2, we injected CNO at ZT5; on day 3, we injected suvorexant at ZT5; on day 5, we injected CNO and suvorexant at ZT5 (Extended Data Fig. 9) .
To validate the specificity and efficacy of AAV DREADD infection following behavioural analysis, mice were given a single injection of CNO (0.5 mg kg −1 in saline) and euthanized 1 h later by terminal anaesthesia and transcardiac perfusion. For G q DREADDs mice, CNO was injected at ZT5, and for G i DREADDs mice, CNO was injected between ZT8 and ZT9. Immunohistochemistry was then performed to detect both mCherry and Fos expression (Extended Data Fig. 7) .
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EEG/EMG analysis. Raw EEG/EMG signals were loaded into Neuroscore (DSI) for scoring. We set the high-pass filter at 0.5 Hz and the low-pass filter at 40 Hz for both EEG channels. EMG signals were high-pass filtered at 10 Hz and low-pass filtered at 100 Hz. EEG1 and EEG2 signals were further transformed to be temporal AR (autoregressive model) spectrums. Researchers were blinded to genotype and/ or treatment before data analysis. Sleep-wake state was visually scored in ~ 10-s periods as either wake (low-voltage, high-frequency EEG wave with high activity of EMG), rapid eye movement (REM, low-voltage, prominent theta frequency in EEG channel and low EMG) or NREM (high-voltage, low-frequency EEG wave with low activity of EMG). The percentage of time spent in each behavioural state was then statistically evaluated.
For investigating the sleep-wake behaviour of Foxd1-cre;Lhx6 lox/lox mice, the EEG/EMG analysis was conducted for 24 h for both Foxd1-cre;Lhx6 lox/+ control and Foxd1-cre;Lhx6 lox/lox mice ( Fig. 3 and Extended Data Fig. 6 ). In our analysis of sleep-wake behaviour in mice expressing activating or silencing DREADDs, we analysed data for 12 h after either saline or CNO injection (Fig. 4) , as effects of CNO were not observed at time points after 10 h post-injection. A 2-h accumulation analysis was also conducted for evaluating temporal dynamics of sleep-wake states.
Sleep deprivation was performed on EEG/EMG chip-implanted mice as previously described 9 and EEG/EMG signals were recorded simultaneously for 6 h of sleep deprivation and 1 h of recovery sleep. The fraction of time spent asleep or awake in each stage during this period was quantified as described above to confirm that the mice were kept awake during the 6 h of sleep deprivation and went to sleep during the 1 h sleep recovery. For the G q DREADDs plus suvorexant drug experiment, we conducted EEG/EMG recordings and analysis as described above to quantify the duration of each sleep-wake stage when treated with CNO, suvorexant or both drugs simultaneously.
For spectral band analysis, we used a previously described methodology 15 . We applied FFT to 5-s epochs of raw EEG waves from extracted NREM or wakefulness episodes separately to calculate EEG power frequency within the frequency range of 0.1-125 Hz. On the basis of the sleep-wake stage labelling, we extracted a 2-h period of raw EEG wave of NREM or wake episodes between ZT7-ZT9 for both Lhx6 cKO and control mice for EEG power spectrum analysis. Similarly, in DREADD experiments, we extracted raw EEG waves of NREM or wake episodes between 2 and 4 h (ZT7-ZT9) after injection with saline or CNO at ZT5 for EEG power spectrum analysis to evaluate the effect of activating or silencing Lhx6 zona incerta neurons. Artefacts were removed from analysis by visual inspection of raw EEG and EMG data. In particular, data epochs that contained noise associated with large movements (EMG muscle artefacts) that occurred during active wake and vigilance states, which cover ~ 10% of the recording interval, were manually flagged and excluded from analysis. Movements were confirmed by analysis of the videotape. In addition, a low-rank approximation was applied to remove the 5% smallest Eigen factors from the raw data, and similar results were obtained to those seen using manual removal of artefacts.
The frequency data was collapsed into 0.5 Hz bins. All spectrum data were averaged for each bin for NREM or wake episodes separately. We then standardized the spectrum data by expressing each frequency bin from NREM or wake episodes for Lhx6 cKO or control mice as a percentage, relative to the same frequency bin and sleep stage in a baseline condition for the same mouse and at the same time of a different day (same zeitgeber time) (Fig. 3c-f) . For DREADD experiments, we standardized the spectrum data by expressing each frequency bin in either saline or the CNO condition as a percentage, relative to the same frequency bin and sleep stage for a baseline condition for the same mouse and at the same time on a different day (same zeitgeber time) (Extended Data Figs 8, 10 ). The standardized frequency data were then averaged among each group of mice. To analyse the EEG frequency bands, relative power bins were summed as follows: delta 0.5-4 Hz, low theta 4-6 Hz, high theta 6-10 Hz, alpha 10-20 Hz, beta 20-40 Hz and gamma 40-100 Hz. All the frequency bins and bands analyses were done using custom software written using MATLAB (MathWorks).
We applied bout length and state transition analysis for all EEG/EMG physiology data (Extended Data Figs 6, 8, 10 ). The sleep-wake stages bout lengths and transition counts were extracted from the same 2-h recording period (ZT7-ZT9) by reading the sleep bout reports (Neuroscore, DSI) automatically with a coding script written using MATLAB (Mathworks). The sleep-wake stage bout lengths and state transitions were averaged for each group of mice. Monosynaptic retrograde tracing with rabies virus. Virus production. The rabies viral vector RVΔ G-4mCherry(EnvA) was made as described 36 . In brief, HEK 293T cells (ATCC CRL-11268) were transfected with expression vectors for the ribozyme-flanked viral genome (pRVΔ G-4mCherry), rabies viral genes (pTIT-N, pTIT-P, pTIT-G and pTIT-L), and the T7 polymerase (pCAG-T7Pol). Supernatants were collected from 4 to 7 days after transfection, filtered, and pooled, passaged 3-4 times in BHK-B19G2 cells 37 at a multiplicity of infection of 2-5, then passaged in BHK-EnvA2 cells 37 at a multiplicity of infection of 2. Purification, concentration and titration were done as described 36, 37 . Adeno-associated viral vector genome plasmid pAAV-Syn-FLEX-splitTVAeGFP-tTA was made from pAAV-Syn-FLEX-sTpEpB 38 by cloning the tetracycline transactivator gene in place of the SAD B19 glycoprotein gene and eliminating the BamHI and NcoI sites in the P2A sequences by seamless cloning. Adeno-associated viral vector genome plasmid pAAV-TREtight-BFP2-B19G was made by cloning the 'TRE-tight' tet response element from pAAV-TRE-HTG 39 , the mTagBFP2 gene 40 , a P2A element and the SAD B19 glycoprotein gene into pAAV-Syn-FLEXsTpEpB 38 by seamless cloning. Genomes were packaged into serotype 1 AAV by the University of North Carolina Vector Core. These AAV genome plasmids and their complete sequences have been deposited with Addgene with accession numbers 100798 and 100799. Surgery. Monosynaptic retrograde tracing using rabies virus was performed as described 14, 38 . Adult Lhx6-cre mice were anaesthetized under 1-2% isoflurane in oxygen with a 0.6-0.8 l per minute flow rate in a stereotaxic apparatus (Kopf). Virus was injected with a microsyringe (Hamilton, 33 GA) and microinjection pump (Hamilton) (rate at 100 nl min
−1
). For rabies virus-based retrograde tracing, mice were injected with 500 nl 1:1 mixed AAV1-Syn-FLEX-splitTVA-eGFP-tTA and AAV1-TREtight-BFP2-B19G in the right zona incerta (AP: − 1.5 mm, ML: + 0.5 mm, DV: − 4.75 mm). After one week, the same mice received the second injection of 300 nl pseudotyped rabies virus RVΔ G-4mCherry(EnvA) using the same coordinates. Control mice were injected with RVΔ G-4mCherry(EnvA) alone, with helper virus omitted. Then mice were transferred to a quarantined cubicle for special housing and monitoring. Seven days after rabies injection, mice were anaesthetized with ketamine and perfused with ice-cold 4% PFA in PBS. Brains were collected and placed in 4% PFA overnight and switched to 30% sucrose for 2-3 days until they were fully sunk. Brains were sectioned on a microtome at a thickness of 40 μ m and stored in the anti-freeze solution at − 20 °C for further usage. Control mice showed no red or green fluorescence in any brain regions examined (data not shown). Electrophysiological recordings in brain slices. Surgery. Postnatal day (P)25-P31 Lhx6-cre;Hcrt-eGFP, Lhx6-cre;Gad2-NLS-mCherry or Lhx6-creER T2 ;Lhx6-GFP mice were anaesthetized with ketamine (50 mg kg −1 ), dexmedetomidine (25 μ m kg −1 ) and the inhalation anaesthetic isoflurane (1-3%) and fixed in a custom-made stereotaxic frame. A small craniotomy was made and 50-100 nl of the AAV9-EF1α -DIO-hChR2(H134R)-mCherry vector (University of Pennsylvania Vector Core) was pressure-injected into the zona incerta (AP: − 1.35 mm, ML: 0.3 mm lateral and DV: − 4.7 mm) through a glass pipet (15-20-μ m tip diameter, Drummond). For experiments performed with Lhx6-cre;Gad2-NLS-mCherry mice, 50-100 nl of AAV9-EF1α -DIO-hChR2(H134R)-eYFP (University of Pennsylvania Vector Core) was injected. The analgesic buprenorphine (0.05 mg kg ;Lhx6-GFP mice only, beginning on the fifth day following viral injection, 0.5 mg of 4-hydroxytamoxifen dissolved in corn oil was administered by intraperitoneal injection once a day for five days to activate expression of Cre recombinase. Mice were euthanized 11-31 days after virus injection for use in electrophysiological experiments. Brain slice preparation and cell identification. Mice were anaesthetized with isoflurane and the brains were rapidly removed and chilled in ice-cold sucrose solution containing (in mM): 76 NaCl, 25 NaHCO 3 , 25 glucose, 75 sucrose, 2.5 KCl, 1.25 NaH 2 PO 4 , 0.5 CaCl 2 and 7 MgSO 4 , pH 7.3. Acute brain slices (300 μ m) were prepared in a coronal orientation using a vibratome (VT-1200s, Leica). Slices were then incubated in warm (32-35 °C) sucrose solution for 30 min, then transferred to warm (32-34 °C) artificial cerebrospinal fluid (ACSF) composed of (in mM): 125 NaCl, 26 NaHCO 3 , 2.5 KCl, 1.25 NaH 2 PO4, 1 MgSO 4 -7H 2 O, 20 d-(+ )-glucose, 2 CaCl 2 -2H 2 O, 0.4 ascorbic acid, 2 pyruvic acid, and 4 l-(+ )-lactic acid, pH 7.3, 315 mOsm, and allowed to cool to room temperature. All solutions were continuously bubbled with 95% O 2 /5% CO 2 .
For whole-cell recordings, slices were transferred to a submersion chamber on an upright microscope (Zeiss AxioExaminer, Objectives: 5× , 0.16 NA and 40× , 1.0 NA) fitted for infrared differential interference contrast (IR-DIC) and fluorescence microscopy. Slices were continuously superfused (2-4 ml min −1 ) with warm oxygenated ACSF (32-34 °C) . Neurons were visualized with a digital camera (Sensicam QE; Cooke) using either transmitted light or epifluorescence. Hcrt neurons in Lhx6-cre;Hcrt-eGFP mice were identified based on their eGFP expression (Extended Data Fig. 5 ). In Lhx6-cre;Gad2-NLS-mCherry mice, Gad2 neurons were identified based on their mCherry expression (Extended Data Fig. 5 ). Because Lhx6 neurons express Gad2, the response to 500 ms of photostimulation with blue light recorded in voltage-clamp was used to eliminate ChR2-expressing Lhx6 neurons from the analysis. In Lhx6-creER T2 ;Lhx6-eGFP mice, Lhx6 neurons were categorized as either ChR2-expressing Lhx6 cells or untransfected cells based on mCherry expression and the response to 500 ms of photostimulation with blue light recorded in voltage-clamp (Extended Data Fig. 5 ).
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Whole-cell recordings and analysis. Glass recording electrodes (2-4 MΩ ) were filled with an internal solution containing (in mM): 36.4 KCl, 96.4 KMeSO 3 , 9.1 HEPES, 0.18 EGTA, 4 MgATP, 0.3 NaGTP, 20 phosphocreatine(Na), pH 7.3, 295 mOsm. Biocytin (0.25% w/v) was added to the internal solution. Whole-cell patch-clamp recordings were obtained using a Multiclamp 700B amplifier (Molecular Devices), low-pass filtered at 10 kHz and digitized at 20-100 kHz using an ITC-18 (Instrutech) controlled by custom software written in Igor Pro (Wavemetrics). The series resistance averaged 11.8 ± 5.6 MΩ (mean ± s.d.) (n = 89 neurons from 17 mice, all < 30 MΩ ) and was not compensated. For ChR2 photoactivation, a small spot (~ 315 μ m diameter) of blue light (6-600 mW per mm 2 ) was delivered as previously described using a blue LED (~ 470 nm; Luminous) 41 and focused onto the recorded cell. Neurons firing spontaneous action potentials were hyperpolarized with small current injections (− 10 to − 70 pA) when measuring postsynaptic responses. Pharmacological experiments used 5 μ M 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f ]quinoxaline-7-sulfonamide disodium salt (NBQX; AMPA receptor antagonist), 5 μ M (RS)-3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP; NMDA receptor antagonist) and 10 μ M 6-imino-3-(4-methoxyphenyl)-1 (6H)-pyridazinebutanoic acid hydrobromide (gabazine; GABA A receptor antagonist). To test for monosynaptic connections, the sodium channel blocker, tetrodotoxin (TTX, 1 μ M) was first applied to the bath to confirm that recorded postsynaptic responses were action-potential dependent. Then the potassium channel blocker 4-AP (100 μ M) was added along with TTX to test for monosynaptic connections 18 . All drugs were purchased from Tocris. The resting membrane potential was measured after whole-cell configuration was achieved. The input resistance was determined by measuring the voltage change in response to a 1-s hyperpolarizing current step (− 10 to − 25 pA). The amplitude of the sag response was calculated as the difference between the minimum membrane potential following the initiation of a − 25-pA current step and the steady-state membrane potential at the end of the 1-s step. Data analysis was performed in Igor Pro (Wavemetrics), Excel (Microsoft), OriginPro 8 (OriginLab) and SigmaPlot (Systat Software). To determine whether Hcrt, Gad2 or Lhx6 neurons in the lateral hypothalamus received Lhx6 input, 20 or more postsynaptic responses to two brief 3-ms photostimulations were first averaged. As a subset of neurons exhibited hyperpolarizing responses shortly after break-in, neurons where the absolute value of the response to the first photostimulation exceeded 0.1 mV and two times the root mean square of the 500 ms preceding the first photostimulation were identified as responsive neurons (Hcrt neurons: 15 out of 20 neurons recorded from four mice responded with one hyperpolarizing response; Gad2 neurons: 17 out of 31 neurons recorded from five mice responded with five hyperpolarizing responses; Lhx6 neurons: 6 out of 18 recorded neurons recorded from three mice responded with two hyperpolarizing responses). To determine the failure rate, each trace was assessed in a similar manner for a response. For responses in Hcrt and Gad2 neurons, the response latency was measured as the time point at which the rise time exceeded 0.1 mV ms −1 in depolarizing responses, except for two Gad2 neurons for which the response was too small to assess. Data are presented as the mean ± s.e.m. unless otherwise noted. Confirmation of the identity of recorded neurons. Brain slices were first fixed in 4% PFA in 0.01 M PBS after recordings, then slices were incubated with blocking buffer containing 2% Triton X-100 (Sigma-Aldrich) and either 5% normal goat serum or 5% normal donkey serum in PBS for 1 h at room temperature. To visualize biocytin-filled cells and confirm their identity, slices were incubated with Alexa Fluor 350-conjugated streptavidin (1:200, S11249, ThermoFisher Scientific) and either chicken anti-GFP antibody (1:300, GFP-1020, Aves) for Hcrt-GFP neurons or rabbit anti-DsRed antibody (1:1,000, 632496, Clontech) for Gad2-mCherry neurons in PBS containing 1% Triton X-100 and 5% corresponding serum overnight. Secondary antibodies used were either Alexa Fluor 488-conjugated goat anti-chicken antibody (1:1,000, A11039, ThermoFisher Scientific) or Alexa Fluor 568-conjugated donkey anti-rabbit antibody (1:1,000, A10042, ThermoFisher Scientific). Images were acquired using a Zeiss Cell Observer and Zeiss 510 confocal microscope. Immunohistochemistry. Mice were anaesthetized with ketamine and transcardially perfused with 20 ml 1× PBS followed by 50 ml of 4% PFA (m/v) in PBS. Brains were removed, fixed overnight in 4% PFA, followed by 30% sucrose (m/v) in PBS overnight in 4 °C for cryoprotection, and embedded and frozen at − 80 °C. Using a cryostat, the frozen brains were sectioned into 40-μ m coronal slices for immunohistochemistry. Immunohistochemistry was performed as described previously with minor changes 9 . Brain sections were washed with 1× PBS and incubated with Superblock (Thermo Scientific, 37515) to block non-specific binding sites. After briefly washing the sections, primary antibodies were diluted in a blocking solution of 5% horse serum in 0.25% Triton X-100 in PBS. The following primary antibodies were used: rabbit anti-GFP (1:500, A-6455, Invitrogen); mouse antiLhx6 (1:100, sc-271433(Clone A-9), Santa Cruz Biotechnology), goat anti-Hrct (1:400, sc-8070, Santa Cruz Biotechnology), rabbit anti-Fos (1:400, sc-52, Santa Cruz Biotechnology), rabbit anti-tyrosine hydroxylase (TH) (1:400, p4010-150, Pel-Freez), rabbit anti-parvalbumin (1:400, PV 27, Swant) and rabbit anti-GABA (1:200, A2052, Sigma-Aldrich). Brain sections were incubated in primary antibodies and blocking solution overnight at 4 °C.
Secondary antibody in blocking solution was then used to incubate the slides for 2 h at room temperature. Secondary antibodies used were: Alexa Fluor 488-conjugated donkey anti-rabbit (1:500, A21206, Invitrogen), Alexa Fluor 488-conjugated donkey anti-mouse (1:500, A212062, Invitrogen), Alexa Fluor 488-conjugated donkey anti-goat (1:500, A11055, Invitrogen), Alexa Fluor 594-conjugated donkey anti-rabbit (1:500, A21207, Invitrogen), Alexa Fluor 594-conjugated donkey anti-mouse (1:500, A21203, Invitrogen) and Alexa Fluor 594-conjugated donkey anti-goat (1:500, A11058, Invitrogen). After washing in 0.1% Triton X-100 in 1× PBS and staining with DAPI (1:5,000, 10236276001, Roche), brain sections were mounted on positively charged slides with Vectashield Mounting medium (H-1500, Vector laboratories). Fluorescent images were taken using a Zeiss Axioskop 2 Mot Plus Microscope or Zeiss Meta 510 LSM confocal microscope.
For staining of rabies virus-injected brain sections, brain sections were washed twice with TBS, followed by permeabilization with 0.5% Triton X-100 TBS for 20 min and blocking with 3.5% donkey serum in TBS + 0.1% Triton X-100 for 30 min. Sections were then incubated in the primary antibody overnight at 4 °C on the shaker. On the second day, brain sections were washed with TBS and then incubated with secondary antibody at room temperature for 2 h. Primary antibodies and their dilutions are as follows: goat anti-GFP (1:500, 600-101-D16, Rockland), rat anti-mCherry (1:500, M11217, Thermo Scientific), mouse anti-Lhx6 (1:400, sc-271433, Santa Cruz), rabbit anti-GABA (1:200, A2052, Sigma-Aldrich), goat anti-ChAT (1:100, Sigma-Aldrich), rabbit anti-HDC (1:1000, 16045, Progen), rabbit anti-Tph2 (1:400, AB111828, Abcam), rabbit anti-TH (1:200, P40101-150, Pel Freez). Images were then acquired with an Olympus FLUOVIEW1000 confocal microscope using a 10× (NA 0.4) or 40× oil (NA 1.30) lens and further processed by ImageJ (Fig. 1k-t 
and Extended Data Figs 2, 4).
Fluorescence in situ hybridization (FISH) with immunohistochemistry. We performed FISH analysis in conjunction with anti-GFP immunohistochemistry on Lhx6-eGFP mice with in situ markers including Gad1 and somatostatin (Sst) (Fig. 1 and Extended Data Fig. 1 ). The RNA probes were generated using the following EST sequences as templates: Gad1 (GenBank accession AI845043), Sst (GenBank accession AI848192). Brains were removed from transgenic Lhx6-eGFP mice within 5 min after euthanasia and fixed overnight in 4% PFA (m/v) in 1× PBS at 4 °C followed by incubation in 30% sucrose (m/v) in PBS overnight in 4 °C for cryoprotection. The embedded and frozen brains were sectioned into 40-μ m sections using a cryostat and then mounted onto positively charged slides. For FISH, all equipment was cleaned with 0.3 M sodium hydroxide and RNaseZap and all solutions were DEPC-treated and autoclaved.
FISH was carried out as previously described 42 with some alterations. In brief, slides were fixed in 4% PFS (m/v) in 1× PBS for 15 min and then cell membranes were digested by incubation in 1 μ g ml −1 proteinase K with 50 mM Tris pH 7.5 and 5 mM EDTA in 1× PBS for 15 min. After re-fixation in 4% PFA, the brain sections underwent acetylation with 0.27% acetic anhydride and 10% 1 M TEA (pH 8) in 1× PBS. The slides were then washed in 1× PBS, incubated in 0.1% Triton X-100 in PBS for 1 h and then quenched in 1% hydrogen peroxide in PBS for 30 min to eliminate endogenous peroxidase activity. Next, the slides were incubated in hybridization buffer (50% formamide, 5× saline sodium citrate (SSC)) for 2 h and incubated overnight under siliconized coverslips in heat-activated DIG-conjugated RNA probes diluted in hybridization buffer at 68 °C. The next day, a 5× SSC wash was followed by two 0.2× SSC washes to remove the coverslips and to eliminate nonspecific probe binding. The slides were then washed with 0.3% Triton X-100 in PBS and incubated in blocking buffer (0.1% Triton X-100, 1% HISS in 1× PBS) for 1 h.
For detection of Lhx6 + neurons, immunohistochemistry for anti-eGFP was combined with the subsequent in situ hybridization steps. The slides were incubated overnight at 4 °C in a blocking solution containing rabbit anti-GFP antibody (1:500, A-6455, Invitrogen) and anti-digoxigenin-POD antibody (1:1,000, 1207733, Roche). After washing the slides in 0.3% Triton X-100 multiple times on the third day, the probe signal was recovered by Cy3-tyramide amplification reagent (1:125, NEL752001KT, TSA Plus cyanine 3/cyanine 5 system, PerkinElmer) in 1× amplification diluent and monitored frequently by fluorescent microscopy for the timing of signal appearance. Slides were washed, quenched in 1% hydrogen peroxide and 0.3% Triton X-100 in PBS and blocked in blocking solution (0.2% Triton X-100, 1% horse serum, 0.1% BSA powder) for 1 h. Primary antibody signal was then detected by species-specific Alexa Fluor 488-conjugated donkey anti-rabbit (1:500; A21206, Invitrogen) incubated with blocking solution for 2 h. Slides were then washed and coverslipped in Vectashield. Fluorescence images were taken using a Zeiss Axioskop 2 Mot Plus Microscope or Zeiss Meta 510 LSM confocal microscope.
Statistics. The experiments were not randomized. No statistical methods were used to predetermine sample size. For Fos immunohistochemistry analysis, each group consisted of data obtained from four mice, a total of four bilateral sections containing the zona incerta was analysed for each mouse, which resulted in interdependence in each group. As a result, to analyse this data, we applied a linear mixed-effect model fit by REML, a non-parametric method, which can resolve issues of interdependence in the Fos data. A two-tailed, one-way ANOVA was used to evaluate the differences among multiple groups. A two-way ANOVA with Bonferonni correction was used to assess pharmacological manipulations in electrophysiological experiments. All sleep-wake data analysis was analysed by two-way ANOVA followed by Sidak's post hoc test, and later confirmed by a non-parametric method, Wilcoxon/Mann-Whitney U-test. Statistical analysis was conducted using the statistical programming language R (R Foundation for Statistical Computing) and Excel (Microsoft). Data availability. Source Data for all figures are provided with the online version of the paper. 
